# OnCo record bone-health-on-hormone-therapy (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/bone-health-on-hormone-therapy/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "bone-health-on-hormone-therapy" ;
  schema:name "Bone health on aromatase inhibitors, ovarian suppression and androgen deprivation therapy"@en ;
  schema:alternateName "bone density scan on aromatase inhibitor"@en, "DEXA on hormone therapy"@en, "cancer treatment-induced bone loss"@en, "osteoporosis on androgen deprivation therapy"@en, "bone protection on letrozole or anastrozole"@en ;
  schema:description "Some hormone treatments for breast and prostate cancer thin the bones and raise the chance of a fracture. When you start an aromatase inhibitor or treatment that stops the ovaries working, a bone density scan is offered; on prostate hormone therapy your fracture risk may be checked. Exercise, a good diet and not smoking help, and bone-strengthening medicine is offered if the bones are thin."@en ;
  schema:url <https://onco.cc/protocols/bone-health-on-hormone-therapy/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "bone-health", "survivorship" ;
  onco:related <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/anastrozole/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/goserelin/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/bone-modifying-agents/>, <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/zoledronic-acid/>, <https://onco.cc/drugs/denosumab/> ;
  onco:institutions <https://onco.cc/institutions/nice/>, <https://onco.cc/institutions/asco/> ;
  onco:terms <https://onco.cc/terms/treatment-induced-bone-loss/>, <https://onco.cc/terms/aromatase-inhibitor/>, <https://onco.cc/terms/adt/> .
